Literature DB >> 7749329

DCC: linking tumor suppressor genes and altered cell surface interactions in cancer?

K R Cho1, E R Fearon.   

Abstract

The gene deleted in colorectal cancer (DCC) is a candidate tumor suppressor gene encoding a neural cell adhesion molecule like transmembrane protein. Over the past year, data supporting DCC inactivation in multiple tumor types have continued to accumulate. Functional studies suggest that DCC may participate in signaling pathways that regulate cell proliferation and/or differentiation, two cellular processes that often go awry during tumorigenesis.

Entities:  

Mesh:

Year:  1995        PMID: 7749329     DOI: 10.1016/s0959-437x(95)90056-x

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  13 in total

1.  Widespread expression of netrin-1 by neurons and oligodendrocytes in the adult mammalian spinal cord.

Authors:  C Manitt; M A Colicos; K M Thompson; E Rousselle; A C Peterson; T E Kennedy
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation.

Authors:  C Forcet; X Ye; L Granger; V Corset; H Shin; D E Bredesen; P Mehlen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Netrin-1 acts as a survival factor via its receptors UNC5H and DCC.

Authors:  F Llambi; F Causeret; E Bloch-Gallego; P Mehlen
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

4.  Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids.

Authors:  S Kytölä; A Höög; B Nord; B Cedermark; T Frisk; C Larsson; M Kjellman
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

5.  APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity.

Authors:  S Reuter; M Bartelmann; M Vogt; C Geisen; I Napierski; T Kahn; H Delius; P Lichter; S Weitz; B Korn; E Schwarz
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

6.  Mammalian homologs of seven in absentia regulate DCC via the ubiquitin-proteasome pathway.

Authors:  G Hu; S Zhang; M Vidal; J L Baer; T Xu; E R Fearon
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

Review 7.  Lessons from the p53 mutant mouse.

Authors:  T Jacks
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

8.  Effect of folate supplementation on mucosal cell proliferation in high risk patients for colon cancer.

Authors:  K Khosraviani; H P Weir; P Hamilton; J Moorehead; K Williamson
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

9.  Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation.

Authors:  C A Schmitt; K R Thaler; B M Wittig; H Kaulen; K H Meyer zum Büschenfelde; W G Dippold
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

10.  Cloning and characterization of a novel gene encoding a putative transmembrane protein with altered expression in some human transformed and tumor-derived cell lines.

Authors:  J Qing; D Wei; V M Maher; J J McCormick
Journal:  Oncogene       Date:  1999-01-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.